Enanta Pharmaceuticals (ENTA) Earnings Date, Estimates & Call Transcripts $12.12 +0.49 (+4.21%) (As of 09/10/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateNov. 18EstimatedActual EPS (Aug. 5) -$1.07 Beat By $0.36 Consensus EPS (Aug. 5) -$1.43 Conference Call TranscriptConference Call AudioEarnings Press Release Get Enanta Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for ENTA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueENTA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ENTA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Timothy Sykes“Why I don’t care if the Fed cuts rates” - SYKES In on Friday out by Monday Over the past decade I’ve made millions of dollars with a strategy I call Weekend Trading. It’s the best strategy I know of - because it revolves around making a quick trade right before the market closes on Friday afternoon… And closing the trade when the market opens the following Monday. I’m hosting a free trading broadcast on Thursday, September 12 at 6 PM ET to show you exactly how y Enanta Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242($2.32)($1.35)($1.84) Q2 20242($2.63)($1.31)($1.97) Q3 20242($1.60)($1.48)($1.54) Q4 20242($1.50)($0.70)($1.10) FY 20248($8.05)($4.84)($6.45) Q1 20251($1.16)($1.16)($1.16) Q2 20251($1.45)($1.45)($1.45) Q3 20251($1.58)($1.58)($1.58) Q4 20251($1.67)($1.67)($1.67) FY 20254($5.86)($5.86) ($5.86)ENTA Earnings Date and InformationEnanta Pharmaceuticals last posted its quarterly earnings results on August 5th, 2024. The biotechnology company reported ($1.07) earnings per share for the quarter, beating the consensus estimate of ($1.43) by $0.36. The business earned $17.97 million during the quarter, compared to the consensus estimate of $17.44 million. Its revenue for the quarter was down 4.9% compared to the same quarter last year. Enanta Pharmaceuticals has generated ($6.24) earnings per share over the last year (($6.24) diluted earnings per share). Earnings for Enanta Pharmaceuticals are expected to grow in the coming year, from ($5.30) to ($5.02) per share. Enanta Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 18th, 2024 based off prior year's report dates.Read More Enanta Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/18/2024(Estimated)------- 8/5/2024Q3 2024($1.43)($1.07)+$0.36($1.07)$17.44 million$17.97 million 5/6/2024Q2 2024($1.26)($1.47)($0.21)($1.47)$16.47 million$17.05 million 2/7/2024Q1 2024($1.18)($1.58)($0.40)($1.58)$22.74 million$18.00 million 11/20/2023Q3 2023($2.11)($1.33)+$0.78($1.33)$17.93 million$18.93 million 8/7/2023Q3 2023($2.38)($1.86)+$0.52($1.86)$15.88 million$18.89 million 5/8/2023Q2 2023($1.91)($1.79)+$0.12($1.79)$19.06 million$17.80 million Get the Latest News and Ratings for ENTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enanta Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/7/2023Q1 2023($1.52)($1.39)+$0.13($1.39)$22.48 million$23.60 million 11/21/2022Q4 2022($1.37)($1.27)+$0.10($1.27)$22.86 million$20.32 million 8/8/2022Q3 2022($1.36)($1.53)($0.17)($1.53)$20.73 million$19.48 million 5/9/2022Q2 2022($1.43)($1.63)($0.20)($1.63)$20.40 million$18.72 million 2/8/2022Q1 2022($1.13)($1.48)($0.35)($1.48)$26.34 million$27.60 million 11/22/2021Q3 2021($1.31)($1.22)+$0.09($1.22)$35.65 million$23.58 million 8/5/2021Q2 2021($1.41)($1.19)+$0.22($1.19)$21.87 million$21.62 million 5/6/2021Q1 2021($0.94)($1.09)($0.15)($1.09)$25.05 million$20.10 million 2/7/2021Q4 2020($0.74)($0.41)+$0.33($0.41)$27.73 million$31.74 million 11/22/2020Q3 2020($0.95)($1.46)($0.51)$0.36$25.63 million$23.63 million 8/4/2020Q2 2020($0.73)($0.71)+$0.02($0.71)$25.47 million$18.70 million 5/6/2020Q1 2020($0.73)($0.30)+$0.43($0.30)$29.16 million$27.60 million 2/6/2020Q1 2020$0.59$0.65+$0.06$0.65$58.75 million$52.57 million 11/21/2019Q3 2019$0.56$0.44($0.12)$0.44$55.95 million$51.30 million Enanta Pharmaceuticals Earnings - Frequently Asked Questions When is Enanta Pharmaceuticals's earnings date? Enanta Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 18th, 2024 based off last year's report dates. Learn more on ENTA's earnings history. Did Enanta Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Enanta Pharmaceuticals (NASDAQ:ENTA) reported ($1.07) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.43) by $0.36. Learn more on analysts' earnings estimate vs. ENTA's actual earnings. How can I listen to Enanta Pharmaceuticals's earnings conference call? The conference call for Enanta Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Enanta Pharmaceuticals's conference call transcript? The conference call transcript for Enanta Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Enanta Pharmaceuticals generate each year? Enanta Pharmaceuticals (NASDAQ:ENTA) has a recorded annual revenue of $79.20 million. How much profit does Enanta Pharmaceuticals generate each year? Enanta Pharmaceuticals (NASDAQ:ENTA) has a recorded net income of -$133.82 million. ENTA has generated -$6.24 earnings per share over the last four quarters. What is Enanta Pharmaceuticals's EPS forecast for next year? Enanta Pharmaceuticals's earnings are expected to grow from ($5.30) per share to ($5.02) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Aligos Therapeutics Earnings ArriVent BioPharma Earnings Praxis Precision Medicines Earnings Evolus Earnings Bicycle Therapeutics Earnings CARGO Therapeutics Earnings Travere Therapeutics Earnings 89bio Earnings Relay Therapeutics Earnings Tectonic Therapeutic Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Is Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 EarningsNVIDIA: Analysts Bullish Ahead of Earnings - Is It a Buy Now? This page (NASDAQ:ENTA) was last updated on 9/11/2024 by MarketBeat.com Staff From Our PartnersFREE TRAINING TODAY ➡️ How to profit from 2024 electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredHow to grow a small trading account into a $100k? Why is Warren Buffett dumping stocks? Billionaires like Warren Buffett, Tim Cook, and Jeff Bezos are offloa...Timothy Sykes | SponsoredKamala's Plan to Bankrupt America—What You Need to KnowWhat if Kamala Wins? The 3 Words That Will Change Everything The same team that predicted Biden’s downfall ...Banyan Hill Publishing | SponsoredWarning For Nvidia HoldersHow The Boeing Disasters Could Hit Nvidia Investors You may have heard about Boeing planes falling apart mi...Stansberry Research | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredYour Crypto Future is at StakeWhat if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...Crypto 101 Media | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enanta Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enanta Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
